Metallo-β-lactamase-producing Pseudomonas spp. in Korea: High prevalence of isolates with VIM-2 type and emergence of isolates with IMP-1 type

Yonsei Medical Journal

Volumn 50, Issue 3, 2009, Pages 335-339

  Lee, Kyungwon ^a   Park, Ae Ja ^b   Kim, Moon Yeun ^c   Lee, Hee Joo ^d   Cho, Ji Hyun ^e   Kang, Jung Oak ^f   Yong, Dongeun ^a   Chong, Yunsop ^a   Ryoon, Namhee ^g   Jeong, Seok Hoon ^h   Ha, Gyoung Yim ^c   Kim, Mi Na ⁱ   Lee, Wee Gyo ^j   Hong, Young Ae ^k   Cho, Soung Eun ^l   Uh, Young ^m   Jang, Sook Jin ⁿ   Lee, Myung Hee ^o   Song, Wonkeun ^p   Choi, Tae Yeal ^f   Shin, Jong Hee ^q   Hong, Seong Geun ^r   Kim, Young Ah ^s   Cho, Dong Hee ^t   Whang, Dong Hee ^u   Lee, Seungok ^v   Lee, Seonghee ^w   more..

^a Yonsei University College of Medicine   (South Korea)

^b Chung Ang University College of Medicine   (South Korea)

^c Dongguk University Gyeongju Hospital   (South Korea)

^d Kyung Hee University College of Medicine   (South Korea)

^e Wonkwang University Hospital   (South Korea)

^f Hanyang University   (South Korea)

^g Keimyung University   (South Korea)

^h Kosin University   (South Korea)

ⁱ University of Ulsan College of Medicine   (South Korea)

^j Ajou University Medical Center   (South Korea)

^k Department of Surgery   (South Korea)

^l Ewha Womans University School of Medicine   (South Korea)

^m Wonju Severance Christian Hospital   (South Korea)

ⁿ Chosun University   (South Korea)

^o Korea Veterans Hospital   (South Korea)

^p Hallym University College of Medicine   (South Korea)

^q Chonnam National University Medical School   (South Korea)

^r CHA University   (South Korea)

^s National Health Insurance Corporation   (South Korea)

^t Samsung Advanced Institute of Technology (SAIT)   (South Korea)

^u Inje University College of Medicine   (South Korea)

^v Seoul Clinical Laboratories   (South Korea)

^w Hanmaeum Hospital   (South Korea)

more..

Author keywords

IMP 1; IMP 6; Korea; Metallo lactamase; VIM 2

Indexed keywords

AMIKACIN; AZTREONAM; BETA LACTAMASE IMP 1; BETA LACTAMASE IMP 6; BETA LACTAMASE VIM 2; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; PIPERACILLIN; TOBRAMYCIN; UNCLASSIFIED DRUG;

ALLELE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; KOREA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PUTIDA;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; ELECTROPHORESIS, GEL, PULSED-FIELD; HUMANS; IMIPENEM; KOREA; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 67651174534     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2009.50.3.335     Document Type: Article

References (23)

1. Nordmann P, Poirel L. Emerging carbapenemases in Gram-negative aerobes. Clin Microbiol Infect 2002;8:321-31.
2. Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-beta-lactamases: the quiet before the storm? Clin Microbiol Rev 2005; 18:306-25.
3. Richet HM, Mohammed J, McDonald LC, Jarvis WR, Building communication networks: international network for the study and prevention of emerging antimicrobial resistance. Emerg Infect Dis 2001;7:319-22.
4. Lee K, Kim YA, Park YJ, Lee HS, Kim MY, Kim EC, et al. Increasing prevalence of vancomycin-resistant enterococci, and cefoxitin-, imipenem- and fluoroquinolone-resistant gram-negative bacilli: a KONSAR study in 2002. Yonsei Med J 2004;45:598-608.
5. Lee K, Lim CH, Cho JH, Lee WG, Uh Y, Kim HJ, et al. High prevalence of ceftazidime-resistant Klebsiella pneumoniae and increase of imipenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. in Korea: a KONSAR program in 2004. Yonsei Med J 2006; 47:634-45.
6. Lee K, Lee WG, Uh Y, Ha GY, Cho J, Chong Y; Korean Nationwide Surveillance of Antimicrobial Resistance Group. VIM- and IMP-type metallo-beta-lactamase-producing Pseudomonas spp. and Acinetobacter spp. in Korean hospitals. Emerg Infect Dis 2003;9: 868-71.
7. Lee K, Ha GY, Shin BM, Kim JJ, Kang JO, Jang SJ, et al. Metallobeta-lactamase-producing Gram-negative bacilli in Korean Nationwide Surveillance of Antimicrobial Resistance group hospitals in 2003: continued prevalence of VIM-producing Pseudomonas spp. and increase of IMP-producing Acinetobacter spp. Diagn Microbiol Infect Dis 2004;50:51-8.
8. Oh EJ, Lee S, Park YJ, Park JJ, Park K, Kim SI, et al. Prevalence of metallo-beta-lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii in a Korean university hospital and comparison of screening methods for detecting metallo-betalactamase. J Microbiol Methods 2003;54:411-8.
9. Kim IS, Lee NY, Ki CS, Oh WS, Peck KR, Song JH. Increasing prevalence of imipenem-resistant Pseudomonas aeruginosa and molecular typing of metallo-beta-lactamase producers in a Korean hospital. Microb Drug Resist 2005;11:355-9.
10. Jeong SH, Lee K, Chong Y, Yum JH, Lee SH, Choi HJ, et al. Characterization of a new integron containing VIM-2, a metallobeta-lactamase gene cassette, in a clinical isolate of Enterobacter cloacae. J Antimicrob Chemother 2003;51:397-400.
11. Lee HK, Park YJ, Kim JY, Chang E, Cho SG, Chae HS, et al. Prevalence of decreased susceptibility to carbapenems among Serratia marcescens, Enterobacter cloacae, and Citrobacter freundii and investigation of carbapenemases. Diagn Microbiol Infect Dis 2005;52:331-6.
12. SIM-1), in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob Agents Chemother 2005;49:4485-91.
13. Kiska DL, Gilligan PH. Pseudomonas. In: Murray PR, Baron EJ, Jorgen Sen JH, Pfaller MA, Yolken RH, editors. Manual of Clinical Microbiology. 8th ed. Washington DC: American Society of Microbiology; 2003. p.719-28.
14. Farmer JJ III. Enterobacteriaceae: introduction and identification. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, editors. Manual of Clinical Microbiology. 8th ed. Washington DC: American Society of Microbiology; 2003. p.636-53.
15. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; Fourteenth informational supplement. M100-S14. Wayne, PA: NCCLS; 2004.
16. Lee K, Lim YS, Yong D, Yum JH, Chong Y. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-beta-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 2003;41:4623-9.
17. Cornaglia G, Hryniewicz W, Jarlier V, Kahlmeter G, Mittermayer H, Stratchounski L, et al. European recommendations for antimicrobial resistance surveillance. Clin Microbiol Infect 2004;10:349-83.
18. Jones RN, Deshpande LM, Bell JM, Turnidge JD, Kohno S, Hirakata Y, et al. Evaluation of the contemporary occurrence rates of metallo-beta-lactamases in multidrug-resistant Gram-negative bacilli in Japan: report from the SENTRY Antimicrobial Surveillance Program (1998-2002). Diagn Microbiol Infect Dis 2004;49: 289-94.
19. Bush K. Metallo-beta-lactamases: a class apart. Clin Infect Dis 1998;27:S48-53.
20. Livermore DM, Woodford N. Carbapenemases: a problem in waiting? Curr Opin Microbiol 2000;3:489-95.
21. Jones RN, Biedenbach DJ, Sader HS, Fritsche TR, Toleman MA, Walsh TR. Emerging epidemic of metallo-beta-lactamase-mediated resistances. Diagn Microbiol Infect Dis 2005;51:77-84.
22. Roh KH, Uh Y, Kim JS, Kim HS, Shin DH, Song W. First outbreak of multidrug-resistant Klebsiella pneumoniae producing both SHV-12-type extended-spectrum beta-lactamase and DHA-1-type AmpC beta-lactamase at a Korean hospital. Yonsei Med J 2008;49:53-7.
23. Osano E, Arakawa Y, Wacharotayankun R, Ohta M, Horii T, Ito H, et al. Molecular characterization of an enterobacterial metallo-betalactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob Agents Chemother 1994; 38:71-8.